Here are three things to know about Mr. Rydin:
1. He previously served as president of global sales for NuVasive and area vice president for DePuy Spine.
2. At DePuy Spine he managed a $100 million division and established the southeastern sales team in the United States.
3. He has served in various leadership positions at Orquest, which was acquired by Johnson & Johnson, and Baxter Healthcare.
Here are three things to know about Mr. Krist:
4. He was CFO at Endologix, a company focused on minimally invasive treatment for aortic disorders. He was responsible for building the company’s financial infrastructure, overseeing several equity capital raises.
5. His experience includes time as CFO at CardioNet and several other executive management positions and public and private healthcare companies.
6. At CardioNet he gained experience developing the business model and overseeing several equity and debt capital raises.
More articles on orthopedic devices:
5 observations on Amedica shares dropping by 15.92%
Global MIS market to grow to $50B+ by 2019: 7 key trends
ExactechGPS launches globally: 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.